
Please try another search
(Reuters) - Pfizer Inc (NYSE:PFE)'s vaccines head Kathrin Jansen, who led the development of the U.S. drugmaker's COVID-19 shot, has decided to retire later this year.
"Over the last two years, Kathrin's legendary resolve, stellar scientific intuition, and vaccine development expertise ushered in the first glimmer of hope for humanity in the middle of the pandemic," Chief Scientific Officer Mikael Dolsten said in a LinkedIn post announcing the retirement.
Pfizer developed the two-dose shot in collaboration with Germany's BioNTech. The vaccine became available in the United States under an emergency use authorization in late 2020 and is now the Western world's most widely used COVID-19 shot.
Jansen, who became the senior vice president of vaccine research and development in 2015, had been the chief scientific officer of the drugmaker's vaccine research and early development research unit.
She previously led vaccine research at vaccines and health care products maker Wyeth, which was acquired by Pfizer over a decade ago.
When contacted, Pfizer pointed to the LinkedIn post by Dolsten without providing additional comment.
By Hyunjoo Jin and Akash Sriram (Reuters) - Tesla (NASDAQ:TSLA) Inc delivered 17.9% fewer electric vehicles in the second quarter from the previous quarter, as China's COVID...
MADRID (Reuters) - Spain-based cabin crew at Ryanair plan to strike for 12 days this month to demand better working conditions, the USO (NYSE:USO) and SICTPLA unions said on...
Tesla (NASDAQ:TSLA) said it delivered 254,695 electric vehicles (EVs) in the second quarter, an increase of 27% on a year-to-year basis. Still, the reported number came below the...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.